BMS Halts Hep C Drug Work After Patient Dies
(MedPage Today) — Bristol-Myers Squibb announced late Thursday that it’s stopping development of an investigational drug for hepatitis C virus infection after a patient died of heart failure and eight others were hospitalized.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com